>

>

Strategic competitive intelligence assessments

Service Areas
Therapeutic Areas

Central Nervous System

Client Type

Mid-size Biotech

Client Problems

  • Understand the competitive landscape for several disease areas


  • Gain insights from the design and success/failures of competitor clinical trials


  • Evaluate strategic importance of PK and/or PD biomarkers


  • Prioritize competitive threats based on a review of competitor MOA, published literature, and execution

What We Did

  • We created a landscape of the current candidates in clinical trials for the disease areas across different MOAs


  • Deep dive on the most relevant clinical trials and the competitor sponsors


  • Gather insights from the clinical trial design of the competitors based on their success/failures and biomarker strategy.

Our Results And Insight

  • Competitive landscape funnel – arranged by phase, MOA and patient characterization


  • Assets under development by class and phase


  • Competitor clinical trial and launch timelines


  • Clinical trial deep dive


  • Clinical trial endpoints and biomarker analysis


  • Insights on clinical trial and biomarker strategy
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png

See other case studies

Commercial Strategy case studies >

Central Nervous System case studies >

Service Areas Details

Commercial Strategy (Competitive Insights)

Therapeutic Areas Details

Central Nervous System (Alzheimer's, Parkinson's, ALS)

Featured Consultants